Oregon

Oregon

  • Colorectal cancer undetectable in patients after participating in immunotherapy study

    Colorectal cancer undetectable in patients after participating in immunotherapy study

    Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.

    Read Article
  • Multi-indication clinical trials help evaluate new medications for future treatments

    Multi-indication clinical trials help evaluate new medications for future treatments

    Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.

    Read Article
  • Providence forensic nurses care for patients and community

    Providence forensic nurses care for patients and community

    Providence’s forensic nurse examiner team care for some of our most vulnerable patients in their most desperate times. See all they do and why they do it.

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • New research lab will focus on improving treatments for soft tissue sarcoma

    New research lab will focus on improving treatments for soft tissue sarcoma

    Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

    Read Article
  • Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

    Read Article
  • GET THE APP ›
  • 5 ways Providence is investing in Oregon’s health

    5 ways Providence is investing in Oregon’s health

    When we talk about how Providence helps others, you might think first of health care for patients. But there are many more ways we support people in our communities.

    Read Article
  • Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference

    Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference

    Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.

    Read Article
  • Two studies assess combination treatments for advanced breast cancers

    Two studies assess combination treatments for advanced breast cancers

    Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

    Read Article
  • FIND A DOCTOR ›
  • Hotspot TCR-T study of gene-engineered adoptive cell therapy for incurable cancers

    Hotspot TCR-T study of gene-engineered adoptive cell therapy for incurable cancers

    Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.

    Read Article
  • Tentative agreement with ONA reached at Providence St. Vincent; talks continue at other area hospitals

    Tentative agreement with ONA reached at Providence St. Vincent; talks continue at other area hospitals

    Providence St. Vincent Medical Center and Oregon Nurses Association labor negotiation teams are pleased to announce that we have have reached a tentative agreement.

    Read Article
  • Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

    Read Article
  • Creating Hope 2022 introduces next generation of immunotherapy

    Creating Hope 2022 introduces next generation of immunotherapy

    A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.

    Read Article
  • LEARN MORE
  • Learn about ovarian cancer treatment and research at virtual patient education event

    Learn about ovarian cancer treatment and research at virtual patient education event

    Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.

    Read Article
  • Clinical trials: Leading breakthroughs in cancer research

    Clinical trials: Leading breakthroughs in cancer research

    May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

    Read Article
  • FIND A CLINIC ›
  • Studies will evaluate combination therapies for two types of melanoma

    Studies will evaluate combination therapies for two types of melanoma

    Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

    Read Article
  • Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

    Read Article
  • Protecting your mental health from global stresses

    Protecting your mental health from global stresses

    Providence Chief Executive of Behavior Health Robin Henderson shares how to protect your mental health in the face of global problems.

    Read Article
  • New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

    Read Article
  • Donate an old bike for Free Bikes 4 Kidz event, April 30

    Donate an old bike for Free Bikes 4 Kidz event, April 30

    You can donate a bike to any one of 23 locations throughout the Portland Metro area, including 11 Providence locations, from 9 a.m. to 1 p.m. on April 30.

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • Living Well with Mantle Cell Lymphoma

    Living Well with Mantle Cell Lymphoma

    Register for a free virtual education event on April 19 for Mantle Cell Lymphoma patients, presented by the Leukemia & Lymphoma Society (LLS) and Providence Cancer Institute of Oregon.

    Read Article
  • loading
    Loading More...